| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
McCarthy Sean A. is a CEO at CytomX Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2025 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 101,793 | $4.54 | $461,906.10 | -9.3% | +35.3% | - | |
| Jun 16, 2025 | CTMX Cytomx Therapeutics, Inc. | CEO | Sale+OE | 55,511 | $2.69 | $149,263.53 | -4.8% | -19.1% | - | |
| Mar 18, 2025 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 37,656 | $0.60 | $22,555.94 | -3.6% | +307.5% | +628.8% | |
| Aug 20, 2024 | CTMX Cytomx Therapeutics, Inc. | CEO | Sale+OE | 13,898 | $1.23 | $17,082.03 | -2.1% | -30.4% | +58.9% | |
| Mar 19, 2024 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 20,223 | $2.09 | $42,175.07 | -3.7% | -37.2% | -69.3% | |
| Dec 20, 2023 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 13,551 | $1.38 | $18,709.87 | -2.9% | +62.7% | -17.9% | |
| Sep 22, 2023 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 14,601 | $1.30 | $18,987.14 | -3.3% | +10.2% | -7.0% | |
| Mar 16, 2023 | CTMX Cytomx Therapeutics, Inc. | CEO | Sell | 7,121 | $1.88 | $13,391.04 | -1.8% | -19.1% | +6.7% | |
| Jul 20, 2022 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sell | 14,911 | $1.42 | $21,206.42 | -4.9% | -6.6% | +18.5% | |
| Jun 16, 2021 | CTMX Cytomx Therapeutics, Inc. | President And CEO | Sell | 100,000 | $7.04 | $704,470.00 | -51.8% | -29.9% | -76.9% |